The use of high-dose methotrexate (HD-MTX) has improved survival rates. This article describes the experience of a patient treated with HD-MTX and outlines the essential aspects of care for the ...
A new study published in the Journal of the European Academy of Dermatology and Venereology found that methotrexate (MTX) has ...
The FDA has expanded the approval for Jylamvo, an oral methotrexate solution, to include pediatric patients with acute ...
Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection ...
A 1-year course of methotrexate may help prevent the development of ACPA-negative RA among patients with clinically suspect arthralgia at high-risk for the disease.
Although high-dose methotrexate is widely accepted as the most effective chemotherapeutic agent for primary CNS lymphoma, no optimal dose or dosing strategy has been established. Researchers from ...
Methotrexate sodium 2.5mg; scored tabs. Be fully familiar with this drug's toxicity before use. Obtain baseline and monitor CBCs for myelosuppression, and hepatic, renal and pulmonary function ...
Visser et al. have published a consensus document on the use and monitoring of methotrexate for rheumatic diseases in clinical practice. 1 The 10 recommendations they describe were derived from a ...
Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of ...
Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic ...
Yes, according to a randomized trial — but with caveats. By 2 years, primary radiographic assessment showed that the percentage of patients without evidence of joint damage was significantly ...
About 1.3 million people in the UK are on methotrexate for conditions such as rheumatoid arthritis and psoriasis. It stops flare-ups, but can make the body less able to fight infections or respond ...